MR is a widely applied method that adopts single nucleotide polymorphisms (SNPs) as instrumental variables (IVs) to replace the exposure (i.e., adiponectin) and outcome (i.e., eGFR, and CKD). This evidence concerns the gene ADIPOQ and chronic kidney disease.